CMSP suppresses oral squamous cell carcinoma progression by targeting the JAK2/STAT3/c-Myc axis
CMSP exerts anti-OSCC effects, at least in part, through modulation of the JAK2/STAT3/c-Myc signaling axis, and may serve as a promising adjunctive therapeutic candidate for OSCC management.
Authors
- Hualin Lu (ORCID: https://orcid.org/0009-0005-4838-9005)
- Daisuke Higuchi (ORCID: https://orcid.org/0000-0001-7197-6068)
- Rui Jin (ORCID: https://orcid.org/0000-0003-4544-6535)
- Manman Yao
- Dixian Wang
- Jiaojiao Zhang (ORCID: https://orcid.org/0000-0002-2699-6729)
- Tiejun Liu (ORCID: https://orcid.org/0000-0001-7522-3936)
- Bo Dong
- Yueting Lu
- Hongyue Shang
Institutions
- Hebei Medical University (CN)
- Hospital of Hebei Province (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Matsumoto Dental University (JP)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-19
- DOI
- https://doi.org/10.3389/fonc.2025.1671797
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00